Related Experiment Videos
Cellular immunity to penicillin in newborns
Acta Allergologica
|February 1, 1977
Insights
Cellular immunity to penicillin (CIP) was studied in newborns. No CIP was detected in untreated infants, but 15% of penicillin-treated newborns showed CIP by day 12.
Area of Science:
- Immunology
- Neonatal Medicine
- Pharmacology
Background:
- Cellular immunity plays a crucial role in response to infections and medications.
- Penicillin is a widely used antibiotic in neonatal care.
- Understanding immune responses in newborns is vital for safe and effective treatment.
Purpose of the Study:
- To investigate the development of cellular immunity to penicillin (CIP) in newborns.
- To determine if penicillin treatment induces a detectable immune response in early neonatal life.
Main Methods:
- Utilized a leukocyte migration micromethod to assess cellular immune responses.
- Studied two groups of newborns: those treated with penicillin and those not treated.
Main Results:
- No detectable cellular immunity to penicillin (CIP) was observed in newborns who had not received penicillin.
- Fifteen percent of newborns treated with penicillin exhibited CIP as early as the 12th day of life.
Conclusions:
- Penicillin treatment can induce a cellular immune response in newborns.
- Early detection of CIP in treated neonates is possible using the leukocyte migration micromethod.
Abstract:
A leukocyte migration micromethod has been used to study the cellular immunity to penicillin (CIP) in newborns. No detectable CIP has been found in newborns who had not been treated with penicillin. Fifteen per cent of the newborns treated with pencillin were found to have a CIP as early as the 12th day of life.